Bollerup S, Engsig F, Hallager S, Mocroft A, Roege BT, Christensen PB, Laursen AL, Krarup H, Clausen MR, Thielsen P, Madsen LG, Noerregaard L, Barfod TS, Balslev U, Tarp B, Hansen JB, Mygind LH, Gerstoft J, Weis N

Journal of Hepatocellular Carcinoma 2022, 9:1093-1104

Published Date: 18 October 2022

Case Series

Delayed Hepatocellular Carcinoma Recurrence After Liver Transplantation: Comprehensive Clinical Characterization of Case Series

Wong TH, Ho CM, Hsu HH, Wu YM, Ho MC, Lee PH, Hu RH

Journal of Hepatocellular Carcinoma 2022, 9:1081-1091

Published Date: 17 October 2022

Original Research

Serum IGF-1 Scores and Clinical Outcomes in the Phase III IMbrave150 Study of Atezolizumab Plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma

Kaseb AO, Guan Y, Gok Yavuz B, Abbas AR, Lu S, Hasanov E, Toh HC, Verret W, Wang Y

Journal of Hepatocellular Carcinoma 2022, 9:1065-1079

Published Date: 11 October 2022

Original Research

The Age, Gamma-Glutamyl Transpeptidase and Platelet Index: A Novel Noninvasive Model for Predicting Hepatocellular Carcinoma in Patients with Hepatitis B Virus-Related Liver Cirrhosis

Liu K, Huang Z, Yang S, Lin L, Zheng S, Zhang X, Xue Y, Xie W

Journal of Hepatocellular Carcinoma 2022, 9:1057-1063

Published Date: 8 October 2022

Original Research

Circular RNA circRASSF5 Functions as an Anti-Oncogenic Factor in Hepatocellular Carcinoma by Acting as a Competitive Endogenous RNA Through Sponging miR-331-3p

Zhou Z, Cui X, Gao P, Zhang X, Zhu C, Sun B

Journal of Hepatocellular Carcinoma 2022, 9:1041-1056

Published Date: 4 October 2022

Review

Circulating Non-Coding RNAs as Potential Diagnostic Biomarkers in Hepatocellular Carcinoma

Chen T

Journal of Hepatocellular Carcinoma 2022, 9:1029-1040

Published Date: 15 September 2022

Review

Assessment and Monitoring of Response to Systemic Treatment in Advanced Hepatocellular Carcinoma: Current Insights

Cammarota A, Zanuso V, Pressiani T, Personeni N, Rimassa L

Journal of Hepatocellular Carcinoma 2022, 9:1011-1027

Published Date: 14 September 2022

Original Research

Hepatic Arterial Infusion Chemotherapy as a Timing Strategy for Conversion Surgery to Treat Hepatocellular Carcinoma: A Single-Center Real-World Study

Wang J, Zheng Z, Wu T, Li W, Wang J, Pan Y, Peng W, Hu D, Hou J, Xu L, Zhang Y, Chen M, Zhang R, Zhou Z

Journal of Hepatocellular Carcinoma 2022, 9:999-1010

Published Date: 14 September 2022

Original Research

Validation of Hepatocellular Carcinoma Risk Prediction Models in Patients with Hepatitis B-Related Cirrhosis

Cheng R, Xu X

Journal of Hepatocellular Carcinoma 2022, 9:987-997

Published Date: 12 September 2022

Original Research

Retrospective Study of the Efficacy and Safety of Chemoembolization with Drug-Eluting Microspheres Combined with Intra-Arterial Infusion of Bevacizumab for Unresectable Hepatocellular Carcinoma

Ueda S, Hori S, Hori A, Makitani K, Wan K, Sonomura T

Journal of Hepatocellular Carcinoma 2022, 9:973-985

Published Date: 12 September 2022

Original Research

Impaired Autophagy Response in Hepatocellular Carcinomas Enriches Glypican-3 in Exosomes, Not in the Microvesicles

Koksal AR, Thevenot P, Aydin Y, Nunez K, Sandow T, Widmer K, Nayak L, Scott J, Delk M, Moehlen MW, Cohen AJ, Dash S

Journal of Hepatocellular Carcinoma 2022, 9:959-972

Published Date: 7 September 2022

Review

Recurrent Hepatocellular Carcinoma: Patterns, Detection, Staging and Treatment

Papaconstantinou D, Tsilimigras DI, Pawlik TM

Journal of Hepatocellular Carcinoma 2022, 9:947-957

Published Date: 3 September 2022

Review

Neoadjuvant Therapy for Hepatocellular Carcinoma

Yin Z, Chen D, Liang S, Li X

Journal of Hepatocellular Carcinoma 2022, 9:929-946

Published Date: 31 August 2022

Original Research

The Prognostic Value of Baseline Clinical and Radiologic Imaging Features in Patients with Unresectable Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab

Awiwi MO, Elsayes KM, Mohamed YI, Altameemi L, Gjoni M, Irshad OM, Sayed Ahmed A, Kaseb AO, Salem U

Journal of Hepatocellular Carcinoma 2022, 9:913-927

Published Date: 30 August 2022

Original Research

A Novel Nomogram for Prediction of Post-Hepatectomy Liver Failure in Patients with Resectable Hepatocellular Carcinoma: A Multicenter Study

Wang J, Zhang Z, Shang D, Liao Y, Yu P, Li J, Chen S, Liu D, Miao H, Li S, Zhang B, Huang A, Liu H, Zhang Y, Qi X

Journal of Hepatocellular Carcinoma 2022, 9:901-912

Published Date: 27 August 2022

Original Research

Identification and Validation in a Novel Classification of Helicase Patterns for the Prediction of Tumor Proliferation and Prognosis

Yin Y, Xu ZY, Liu YJ, Huang W, Zhang Q, Li JP, Zou X

Journal of Hepatocellular Carcinoma 2022, 9:885-900

Published Date: 27 August 2022

Original Research

Lipid-Based Factors: A Promising New Biomarker for Predicting Prognosis and Conditional Survival Probability in Hepatocellular Carcinoma

Guo Z, Liang J

Journal of Hepatocellular Carcinoma 2022, 9:869-883

Published Date: 26 August 2022

Review

Pathogenesis from Inflammation to Cancer in NASH-Derived HCC

Yu S, Wang J, Zheng H, Wang R, Johnson N, Li T, Li P, Lin J, Li Y, Yan J, Zhang Y, Zhu Z, Ding X

Journal of Hepatocellular Carcinoma 2022, 9:855-867

Published Date: 26 August 2022

Corrigendum

Experimental Validation of Novel Glypican 3 Exosomes for the Detection of Hepatocellular Carcinoma in Liver Cirrhosis [Corrigendum]

Aydin Y, Koksal AR, Thevenot P, Chava S, Heidari Z, Lin D, Sandow T, Moroz K, Parsi MA, Scott J, Cohen A, Dash S

Journal of Hepatocellular Carcinoma 2022, 9:853-854

Published Date: 29 August 2022

Original Research

Extending Surgical Resection for Hepatocellular Carcinoma Beyond Barcelona Clinic for Liver Cancer (BCLC) Stage A: A Novel Application of the Modified BCLC Staging System

Wee IJY, Moe FNN, Sultana R, Ang RWT, Quek PPS, Goh BKP, Chan CY, Cheow PC, Chung AYF, Jeyaraj PR, Koh YX, Mack POP, Ooi LLPJ, Tan EK, Teo JY, Kam JH, Chua JSS, Ng AWY, Goh JSQ, Chow PKH

Journal of Hepatocellular Carcinoma 2022, 9:839-851

Published Date: 17 August 2022

Original Research

Disruption of Growth Hormone Receptor Signaling Abrogates Hepatocellular Carcinoma Development

Haque A, Sahu V, Lombardo JL, Xiao L, George B, Wolff RA, Morris JS, Rashid A, Kopchick JJ, Kaseb AO, Amin HM

Journal of Hepatocellular Carcinoma 2022, 9:823-837

Published Date: 15 August 2022

Original Research

Safety and Efficacy of Drug-Eluting Beads Trans-Arterial Chemoembolization for Hepatocellular Carcinoma in Taiwan (SERENADE-T)

Liu YS, Chang PY, Liang PC, Ou MC, Hwang JI, Chen CH

Journal of Hepatocellular Carcinoma 2022, 9:811-821

Published Date: 15 August 2022

Original Research

Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study

Gan L, Ren S, Lang M, Li G, Fang F, Chen L, Liu Y, Han R, Zhu K, Song T

Journal of Hepatocellular Carcinoma 2022, 9:799-810

Published Date: 13 August 2022

Original Research

Effect of Transarterial Chemoembolization Plus Percutaneous Ethanol Injection or Radiofrequency Ablation for Liver Tumors

Chen L, Zhang W, Sun T, Ren Y, Sun B, Zhu L, Zhao H, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:783-797

Published Date: 12 August 2022

Original Research

Rethinking Liver Fibrosis Staging in Patients with Hepatocellular Carcinoma: New Insights from a Large Two-Center Cohort Study

Xu W, Li B, Yang Z, Li J, Liu F, Liu Y

Journal of Hepatocellular Carcinoma 2022, 9:751-781

Published Date: 12 August 2022

Original Research

Vitamin B6 Metabolic Pathway is Involved in the Pathogenesis of Liver Diseases via Multi-Omics Analysis

Mei M, Liu D, Tang X, You Y, Peng B, He X, Huang J

Journal of Hepatocellular Carcinoma 2022, 9:729-750

Published Date: 11 August 2022

Original Research

Nomogram for the Preoperative Prediction of the Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma

Shan Y, Yu X, Yang Y, Sun J, Wu S, Mao S, Lu C

Journal of Hepatocellular Carcinoma 2022, 9:717-728

Published Date: 10 August 2022

Original Research

Does HCC Etiology Impact the Efficacy of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma? An Asian Liver Radiation Therapy Group Study

Kim N, Cheng JCH, Ohri N, Huang WY, Kimura T, Zeng ZC, Lee VHF, Kay CS, Seong J

Journal of Hepatocellular Carcinoma 2022, 9:707-715

Published Date: 6 August 2022

Original Research

Transarterial Chemoebolization in Hepatocellular Carcinoma: A Binational Japanese-German Study

Auer TA, Sofue K, Ueshima E, Rauer N, Yamaguchi T, Gebauer B, Hamm B, Murakami T, Althoff CE

Journal of Hepatocellular Carcinoma 2022, 9:695-705

Published Date: 1 August 2022

Original Research

Comparison of the Efficacy and Safety of Transarterial Chemoembolization with or without Lenvatinib for Unresectable Hepatocellular Carcinoma: A Retrospective Propensity Score–Matched Analysis

Chen YX, Zhang JX, Zhou CG, Liu J, Liu S, Shi HB, Zu QQ

Journal of Hepatocellular Carcinoma 2022, 9:685-694

Published Date: 1 August 2022

Original Research

A Machine Learning Model Based on Health Records for Predicting Recurrence After Microwave Ablation of Hepatocellular Carcinoma

An C, Yang H, Yu X, Han Z, Cheng Z, Liu F, Dou J, Li B, Li Y, Li Y, Yu J, Liang P

Journal of Hepatocellular Carcinoma 2022, 9:671-684

Published Date: 28 July 2022

Review

Macrotrabecular-Massive Hepatocellular Carcinoma: Light and Shadow in Current Knowledge

Sessa A, Mulé S, Brustia R, Regnault H, Galletto Pregliasco A, Rhaiem R, Leroy V, Sommacale D, Luciani A, Calderaro J, Amaddeo G

Journal of Hepatocellular Carcinoma 2022, 9:661-670

Published Date: 27 July 2022

Original Research

Preoperative Prognostic Nutritional Index May Be a Strong Predictor of Hepatocellular Carcinoma Recurrence Following Liver Transplantation

Kornberg A, Kaschny L, Kornberg J, Friess H

Journal of Hepatocellular Carcinoma 2022, 9:649-660

Published Date: 27 July 2022

Original Research

Histological Severity of Cirrhosis Influences Surgical Outcomes of Hepatocellular Carcinoma After Curative Hepatectomy

Liang BY, Gu J, Xiong M, Zhang EL, Zhang ZY, Lau WY, Wang SF, Guan Y, Chen XP, Huang ZY

Journal of Hepatocellular Carcinoma 2022, 9:633-647

Published Date: 23 July 2022

Original Research

Effects of Early TACE Refractoriness on Survival in Patients with Hepatocellular Carcinoma: A Real-World Study

Yang C, Luo YG, Yang HC, Yao ZH, Li X

Journal of Hepatocellular Carcinoma 2022, 9:621-631

Published Date: 21 July 2022

Original Research

Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and Cirrhosis

Hammad R, Eldosoky MA, Mosaad AM, El-Nasser AM, Kotb FM, Elshennawy SI, Eldesoky NAR, Selim MA, Naguib GG, Ahmed OA, Alboraie M, Aglan RB

Journal of Hepatocellular Carcinoma 2022, 9:609-619

Published Date: 18 July 2022

Original Research

Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis

Sagmeister P, Daza J, Ofner A, Ziesch A, Ye L, Ben Khaled N, Ebert M, Mayerle J, Teufel A, De Toni EN, Munker S

Journal of Hepatocellular Carcinoma 2022, 9:595-607

Published Date: 9 July 2022

Review

Understanding the Role of Metabolic Syndrome as a Risk Factor for Hepatocellular Carcinoma

Chavez-Tapia NC, Murúa-Beltrán Gall S, Ordoñez-Vázquez AL, Nuño-Lambarri N, Vidal-Cevallos P, Uribe M

Journal of Hepatocellular Carcinoma 2022, 9:583-593

Published Date: 5 July 2022

Review

Neoadjuvant Immunotherapy for Hepatocellular Carcinoma

Marron TU, Schwartz M, Corbett V, Merad M

Journal of Hepatocellular Carcinoma 2022, 9:571-581

Published Date: 30 June 2022

Original Research

CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation

Zhang S, Jiang M, Cao H, Xiong J, Xu J

Journal of Hepatocellular Carcinoma 2022, 9:553-569

Published Date: 7 June 2022

Original Research

Tumor Response and Nomogram-Based Prognostic Stratification for Hepatocellular Carcinoma After Drug-Eluting Beads Transarterial Chemoembolization

Ji K, Zhu H, Wu W, Li X, Zhan P, Shi Y, Sun J, Li Z

Journal of Hepatocellular Carcinoma 2022, 9:537-551

Published Date: 7 June 2022

Review

Trial Designs for Integrating Novel Therapeutics into the Management of Intermediate-Stage Hepatocellular Carcinoma

Su YY, Liu YS, Hsiao CF, Hsu C, Chen LT

Journal of Hepatocellular Carcinoma 2022, 9:517-536

Published Date: 2 June 2022

Original Research

Identification of KRBA1 as a Potential Prognostic Biomarker Associated with Immune Infiltration and m6A Modification in Hepatocellular Carcinoma

Liu Y, Fu B, Yu Z, Song G, Zeng H, Gong Y, Ding Y, Huang D

Journal of Hepatocellular Carcinoma 2022, 9:497-516

Published Date: 31 May 2022

Review

Hepatocellular Carcinoma Due to Nonalcoholic Fatty Liver Disease: Current Concepts and Future Challenges

Ahmad MI, Khan MU, Kodali S, Shetty A, Bell SM, Victor D

Journal of Hepatocellular Carcinoma 2022, 9:477-496

Published Date: 1 June 2022

Original Research

The Prognostic Role of Circulating FPR Before Operation in Patients with BCLC A-C Hepatocellular Carcinoma: A Retrospective Cohort Study

Shen Y, Xu Y, Wei J, Li W

Journal of Hepatocellular Carcinoma 2022, 9:467-476

Published Date: 31 May 2022

Original Research

CT-Based Radiomics for the Recurrence Prediction of Hepatocellular Carcinoma After Surgical Resection

Wang F, Chen Q, Zhang Y, Chen Y, Zhu Y, Zhou W, Liang X, Yang Y, Hu H

Journal of Hepatocellular Carcinoma 2022, 9:453-465

Published Date: 23 May 2022

Original Research

Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility Study

Ruan SM, Cheng MQ, Huang H, Hu HT, Li W, Xie XY, Lu MD, Kuang M, Lin MX, Wang W

Journal of Hepatocellular Carcinoma 2022, 9:437-451

Published Date: 20 May 2022

Original Research

Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma

Zhang G

Journal of Hepatocellular Carcinoma 2022, 9:423-436

Published Date: 19 May 2022

Original Research

RNA Binding Motif Protein 3 Promotes Cell Metastasis and Epithelial–Mesenchymal Transition Through STAT3 Signaling Pathway in Hepatocellular Carcinoma

Zhang L, Zhang Y, Shen D, Chen Y, Feng J, Wang X, Ma L, Liao Y, Tang L

Journal of Hepatocellular Carcinoma 2022, 9:405-422

Published Date: 9 May 2022

Original Research

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology

Zhao D, Zhang X, Tang Y, Guo P, Ai R, Hou M, Wang Y, Yuan X, Cui L, Zhang Y, Zhao S, Li W, Wang Y, Sun X, Liu L, Dong S, Li L, Zhao W, Nan Y

Journal of Hepatocellular Carcinoma 2022, 9:389-403

Published Date: 9 May 2022

Review

Macrotrabecular-Massive Hepatocellular Carcinoma: What Should We Know?

Li X, Yao Q, Liu C, Wang J, Zhang H, Li S, Cai P

Journal of Hepatocellular Carcinoma 2022, 9:379-387

Published Date: 5 May 2022

Original Research

Nonsynonymous C1653T Mutation of Hepatitis B Virus X Gene Enhances Malignancy of Hepatocellular Carcinoma Cells

Zhang C, Xie Y, Lai R, Wu J, Guo Z

Journal of Hepatocellular Carcinoma 2022, 9:367-377

Published Date: 3 May 2022

Original Research

Skull Base Metastasis from Hepatocellular Carcinoma: Clinical Presentation and Efficacy of Radiotherapy

Kim K, Lee J, Seong J

Journal of Hepatocellular Carcinoma 2022, 9:357-366

Published Date: 29 April 2022

Review

An Overview of Hepatocellular Carcinoma After Insufficient Radiofrequency Ablation

Guo Y, Ren Y, Dong X, Kan X, Zheng C

Journal of Hepatocellular Carcinoma 2022, 9:343-355

Published Date: 26 April 2022

Original Research

Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression

Yu CL, Lee HL, Yang SF, Wang SW, Lin CP, Hsieh YH, Chiou HL

Journal of Hepatocellular Carcinoma 2022, 9:327-341

Published Date: 24 April 2022

Original Research

Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients

Hu Z, Sun X, Mei J, Hu Z, Yang Z, Hou J, Fu Y, Wang X, Chen M

Journal of Hepatocellular Carcinoma 2022, 9:315-325

Published Date: 19 April 2022

Original Research

Impact of PNPLA3 p.I148M and Hepatic Steatosis on Long-Term Outcomes for Hepatocellular Carcinoma and HBsAg Seroclearance in Chronic Hepatitis B

Hsueh RC, Wu WJ, Lin CL, Liu CJ, Huang YW, Hu JT, Wu CF, Sung FY, Liu WJ, Yu MW

Journal of Hepatocellular Carcinoma 2022, 9:301-313

Published Date: 11 April 2022

Original Research

MCT4 Promotes Hepatocellular Carcinoma Progression by Upregulating TRAPPC5 Gene

Niu Z, Yang F, Li H, Wang J, Ni Q, Ma C, Zhu H, Chang H, Zhou X, Lu J, Gao H

Journal of Hepatocellular Carcinoma 2022, 9:289-300

Published Date: 8 April 2022

Original Research

Noninvasive Imaging Evaluation Based on Computed Tomography of the Efficacy of Initial Transarterial Chemoembolization to Predict Outcome in Patients with Hepatocellular Carcinoma

Dai Y, Jiang H, Feng ST, Xia Y, Li J, Zhao S, Wang D, Zeng X, Chen Y, Xin Y, Liu D

Journal of Hepatocellular Carcinoma 2022, 9:273-288

Published Date: 5 April 2022

Original Research

Safety and Efficacy of Transarterial Chemoembolization and Immune Checkpoint Inhibition with Camrelizumab for Treatment of Unresectable Hepatocellular Carcinoma

Zhang JX, Chen P, Liu S, Zu QQ, Shi HB, Zhou CG

Journal of Hepatocellular Carcinoma 2022, 9:265-272

Published Date: 31 March 2022

Review

Systemic Therapy for Hepatocellular Carcinoma: Current Updates and Outlook

Fan Y, Xue H, Zheng H

Journal of Hepatocellular Carcinoma 2022, 9:233-263

Published Date: 30 March 2022

Original Research

Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer

Ren P, Wang K, Ma J, Cao X, Zhao J, Zhao C, Guo Y, Ye H

Journal of Hepatocellular Carcinoma 2022, 9:221-232

Published Date: 29 March 2022

Original Research

LRP1B is a Potential Biomarker for Tumor Immunogenicity and Prognosis of HCC Patients Receiving ICI Treatment

Cheng Y, Tang R, Li X, Wang B, Cheng Y, Xiao S, Sun P, Yu W, Li C, Lin X, Zhu Y

Journal of Hepatocellular Carcinoma 2022, 9:203-220

Published Date: 22 March 2022

Original Research

Preoperative Radiomics Analysis of Contrast-Enhanced CT for Microvascular Invasion and Prognosis Stratification in Hepatocellular Carcinoma

Xu T, Ren L, Liao M, Zhao B, Wei R, Zhou Z, He Y, Zhang H, Chen D, Chen H, Liao W

Journal of Hepatocellular Carcinoma 2022, 9:189-201

Published Date: 20 March 2022

Original Research

Borealin Promotes Tumor Growth and Metastasis by Activating the Wnt/β-Catenin Signaling Pathway in Hepatocellular Carcinoma

Chen B, Gu Y, Shen H, Liu Q, Wang H, Li Y, Liu X, Liu Y, Du Q, Sun H, Liao X

Journal of Hepatocellular Carcinoma 2022, 9:171-188

Published Date: 11 March 2022

Original Research

Regorafenib Combined with PD-1 Blockade Immunotherapy versus Regorafenib as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Study

Huang J, Guo Y, Huang W, Hong X, Quan Y, Lin L, Zhou J, Liang L, Zhang Y, Zhou J, Cai M, Zhu K

Journal of Hepatocellular Carcinoma 2022, 9:157-170

Published Date: 10 March 2022

Original Research

The Oncogenic and Diagnostic Potential of Stanniocalcin 2 in Hepatocellular Carcinoma

Wu Z, Cheng H, Liu J, Zhang S, Zhang M, Liu F, Li Y, Huang Q, Jiang Y, Chen S, Lv L, Li D, Zeng JZ

Journal of Hepatocellular Carcinoma 2022, 9:141-155

Published Date: 8 March 2022

Original Research

Postoperative Adjuvant Transarterial Chemoembolization Plus Tyrosine Kinase Inhibitor for Hepatocellular Carcinoma: a Multicentre Retrospective Study

Lin K, Wei F, Huang Q, Lai Z, Zhang J, Chen Q, Jiang Y, Kong J, Tang S, Lin J, Chen Y, Chen J, Zeng Y

Journal of Hepatocellular Carcinoma 2022, 9:127-140

Published Date: 8 March 2022

Original Research

MicroRNA-128-3p Mediates Lenvatinib Resistance of Hepatocellular Carcinoma Cells by Downregulating c-Met

Xu X, Jiang W, Han P, Zhang J, Tong L, Sun X

Journal of Hepatocellular Carcinoma 2022, 9:113-126

Published Date: 27 February 2022

Review

Current Perspectives on the Unique Roles of Exosomes in Drug Resistance of Hepatocellular Carcinoma

Xue D, Han J, Liang Z, Jia L, Liu Y, Tuo H, Peng Y

Journal of Hepatocellular Carcinoma 2022, 9:99-112

Published Date: 18 February 2022

Original Research

SLC39A1 Overexpression is Associated with Immune Infiltration in Hepatocellular Carcinoma and Promotes Its Malignant Progression

Ma X, Zhuang H, Wang Q, Yang L, Xie Z, Zhang Z, Tan W, Tang C, Chen Y, Shang C

Journal of Hepatocellular Carcinoma 2022, 9:83-98

Published Date: 15 February 2022

Original Research

Hepatocellular Carcinoma Risk Prediction in the NIH-AARP Diet and Health Study Cohort: A Machine Learning Approach

Thomas J, Liao LM, Sinha R, Patel T, Antwi SO

Journal of Hepatocellular Carcinoma 2022, 9:69-81

Published Date: 15 February 2022

Original Research

CtBP1 Mediates Hypoxia-Induced Sarcomatoid Transformation in Hepatocellular Carcinoma

Zhang X, Wang X, Jia L, Yang Y, Yang F, Xiao S

Journal of Hepatocellular Carcinoma 2022, 9:57-67

Published Date: 11 February 2022

Review

Current Perspective of Traditional Chinese Medicines and Active Ingredients in the Therapy of Hepatocellular Carcinoma

Li Y, Li Y, Zhang J, Ji L, Li M, Sun X, Feng H, Yu Z, Gao Y

Journal of Hepatocellular Carcinoma 2022, 9:41-56

Published Date: 9 February 2022

Original Research

Dynamic Lymphocyte Changes Following Transarterial Radioembolization: Association with Normal Liver Dose and Effect on Overall Survival

Young S, Ragulojan R, Chen T, Owen J, D'souza D, Sanghvi T, Golzarian J, Flanagan S

Journal of Hepatocellular Carcinoma 2022, 9:29-39

Published Date: 4 February 2022

Retraction

Drug-Eluting Bead Transarterial Chemoembolization versus Conventional Transarterial Chemoembolization Both Combined Apatinib for Hepatocellular Carcinoma: A Retrospective, Propensity-Score Matched Study [Retraction]

Ouyang T, Liu J, Shi C, Zhu L, Guo X

Journal of Hepatocellular Carcinoma 2022, 9:27-28

Published Date: 28 January 2022

Original Research

Surgical Strategy for Resecting Hepatocellular Carcinoma in the Caudate Lobe: Isolated or Combined Lobectomy? A Single-Center Study and Meta-Analysis

Xu ZG, Zhang FH, Sun DW, Zheng QT, Ji GW, Wang K

Journal of Hepatocellular Carcinoma 2022, 9:13-25

Published Date: 26 January 2022

Original Research

Factors Associated with Survival of Hepatocellular Carcinoma (HCC) Patients at a Safety Net Hospital in Arizona without On-Site Liver Transplant Program

Turse E, Aboona M, Charley E, Forlemu A, Bowie T, Bhattarai B, Chuang KY, Nadir A

Journal of Hepatocellular Carcinoma 2022, 9:1-11

Published Date: 22 January 2022